Literature DB >> 26016624

Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests.

M M Lauridsen1, O B Schaffalitzky de Muckadell, H Vilstrup.   

Abstract

Minimal hepatic encephalopathy (MHE) is a frequent complication to liver cirrhosis that causes poor quality of life, a great burden to caregivers, and can be treated. For diagnosis and grading the international guidelines recommend the use of psychometric tests of different modalities (computer based vs. paper and pencil). To compare results of the Continuous Reaction time (CRT) and the Portosystemic Encephalopathy (PSE) tests in a large unselected cohort of cirrhosis patients without clinically detectable brain impairment and to clinically characterize the patients according to their test results. The CRT method is a 10-minute computerized test of a patient's motor reaction time stability (CRTindex) to 150 auditory stimuli. The PSE test is a 20-minute paper-pencil test evaluating psychomotor speed. Both tests were performed at the same occasion in 129 patients. Both tests were normal in only 36% (n = 46) of the patients and this group had the best quality of life, a normal CRP, a low risk of subsequent overt HE, and a low short term mortality. Either the CRT or the PSE test was abnormal in a total of 64% of the patients (n = 83), the CRT in 53% (n = 69) and the PSE in 34% (n = 44). All these patients had a poorer quality of life, low-grade CRP elevation, moderate risk for subsequent overt HE, and a higher than 20% short term mortality. Both tests were abnormal in 23% (n = 30) of the patients and this group had more advanced cirrhosis and a 40 % short-term mortality. One of the tests was abnormal in the majority of the patients but concordant in only 60%. Most cirrhosis patients seem to have impairments of different cognitive domains and more domains with advancing disease. Two abnormal tests identified patients with an increased risk of overt HE and death.

Entities:  

Mesh:

Year:  2015        PMID: 26016624     DOI: 10.1007/s11011-015-9688-7

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  31 in total

Review 1.  Quality of life in cirrhotics with minimal hepatic encephalopathy.

Authors:  H Schomerus; W Hamster
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

2.  Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis.

Authors:  Mette Munk Lauridsen; Henning Grønbæk; Esben B Næser; Steffen T Leth; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2012-05-22       Impact factor: 3.584

Review 3.  Psychometric tests for diagnosing minimal hepatic encephalopathy.

Authors:  Karin Weissenborn
Journal:  Metab Brain Dis       Date:  2012-09-21       Impact factor: 3.584

4.  Prevalence of minimal hepatic encephalopathy in cirrhotic patients.

Authors:  Héctor Jesús Maldonado-Garza; Genaro Vázquez-Elizondo; Juan Obed Gaytán-Torres; Angel Ricardo Flores-Rendón; Martha Graciela Cárdenas-Sandoval; Francisco Javier Bosques-Padilla
Journal:  Ann Hepatol       Date:  2011-06       Impact factor: 2.400

5.  Development of quantitative neuropsychological tests for diagnosis of subclinical hepatic encephalopathy in liver cirrhosis patients and establishment of diagnostic criteria-multicenter collaborative study in Japanese.

Authors:  Akinobu Kato; Motoichiro Kato; Hiromasa Ishii; Yosuke Ichimiya; Kazuyuki Suzuki; Hironaka Kawasaki; Shin-Ichiro Yamamoto; Ryukichi Kumashiro; Kyosuke Yamamoto; Naohiro Kawamura; Naoaki Hayashi; Shohei Matsuzaki; Akira Terano; Kiwamu Okita; Akiharu Watanabe
Journal:  Hepatol Res       Date:  2004-10       Impact factor: 4.288

Review 6.  Recent insights into the pathogenesis of hepatic encephalopathy and treatments.

Authors:  Jonathan P Sturgeon; Debbie L Shawcross
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2014-01       Impact factor: 3.869

7.  Diagnosis of covert hepatic encephalopathy without specialized tests.

Authors:  Eiman Nabi; Leroy R Thacker; James B Wade; Richard K Sterling; R Todd Stravitz; Michael Fuchs; Douglas M Heuman; Iliana Bouneva; Arun J Sanyal; Mohammad S Siddiqui; Velimir Luketic; Melanie B White; Pamela Monteith; Nicole A Noble; Ariel Unser; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2013-12-19       Impact factor: 11.382

8.  Discrimination between organic and hepatic encephalopathy by means of continuous reaction times.

Authors:  P Elsass; S E Christensen; E L Mortensen; H Vilstrup
Journal:  Liver       Date:  1985-02

9.  Subclinical hepatic encephalopathy impairs daily functioning.

Authors:  M Groeneweg; J C Quero; I De Bruijn; I J Hartmann; M L Essink-bot; W C Hop; S W Schalm
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

10.  Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China.

Authors:  Su-Wen Li; Kai Wang; Yong-Qiang Yu; Hai-Bao Wang; Yuan-Hai Li; Jian-Ming Xu
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

View more
  11 in total

1.  Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy.

Authors:  Massimo Marano; Umberto Vespasiani Gentilucci; Claudia Altamura; Mariacristina Siotto; Rosanna Squitti; Serena Bucossi; Livia Quintiliani; Simone Migliore; Federico Greco; Laura Scarciolla; Carlo Cosimo Quattrocchi; Antonio Picardi; Fabrizio Vernieri
Journal:  Metab Brain Dis       Date:  2015-08-27       Impact factor: 3.584

Review 2.  Qualifying and quantifying minimal hepatic encephalopathy.

Authors:  Marsha Y Morgan; Piero Amodio; Nicola A Cook; Clive D Jackson; Gerald Kircheis; Mette M Lauridsen; Sara Montagnese; Sami Schiff; Karin Weissenborn
Journal:  Metab Brain Dis       Date:  2015-09-28       Impact factor: 3.584

3.  In Patients With Cirrhosis, Driving Simulator Performance Is Associated With Real-life Driving.

Authors:  Mette M Lauridsen; Leroy R Thacker; Melanie B White; Ariel Unser; Richard K Sterling; Richard T Stravitz; Scott Matherly; Puneet Puri; Arun J Sanyal; Edith A Gavis; Velimir Luketic; Muhammad S Siddiqui; Douglas M Heuman; Michael Fuchs; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2015-11-19       Impact factor: 11.382

4.  Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients.

Authors:  Ting-Ting Jiang; Xiao-Li Liu; Yu-Yong Jiang; Xian-Bo Wang; Zhi-Yun Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-07       Impact factor: 2.629

Review 5.  Liver-related effects of chronic hepatitis C antiviral treatment.

Authors:  Tea L Laursen; Thomas D Sandahl; Konstantin Kazankov; Jacob George; Henning Grønbæk
Journal:  World J Gastroenterol       Date:  2020-06-14       Impact factor: 5.742

6.  The Prevalence and Association of Cognitive Impairment with Sleep Disturbances in Patients with Chronic Liver Disease.

Authors:  Oana-Mihaela Plotogea; Camelia Cristina Diaconu; Gina Gheorghe; Madalina Stan-Ilie; Mircea-Alexandru Badea; Cristina Cijevschi Prelipcean; Gabriel Constantinescu
Journal:  Brain Sci       Date:  2022-03-26

7.  Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy.

Authors:  Karen Louise Thomsen; Jane Macnaughtan; Giovanni Tritto; Rajeshwar P Mookerjee; Rajiv Jalan
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

8.  The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention-A pilot study.

Authors:  M M Lauridsen; S Mikkelsen; T Svensson; J Holm; C Klüver; J Gram; H Vilstrup; O B Schaffalitzky de Muckadell
Journal:  PLoS One       Date:  2017-10-11       Impact factor: 3.240

9.  Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis.

Authors:  Charlotte W Wernberg; Ove B Schaffalitzky de Muckadell; Hendrik Vilstrup; Mette M Lauridsen
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

10.  Validation of a Simple Quality-of-Life Score for Identification of Minimal and Prediction of Overt Hepatic Encephalopathy.

Authors:  Mette Munk Lauridsen; Peter Jepsen; Charlotte Wilhelmina Wernberg; Ove B Schaffalitzky de Muckadell; Jasmohan S Bajaj; Hendrik Vilstrup
Journal:  Hepatol Commun       Date:  2020-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.